Table 2 Clinical characteristics of patients with positive results using RAPIRUN with nasopharyngeal swabs
All pneumococcal pneumonia patients (n = 17) | Patients with positive results using RAPIRUN with nasopharyngeal swabs (n = 4) | |||
|---|---|---|---|---|
Age, years, median (range) | 78 | (28–96) | 79.5 | (76–87) |
Male sex, n (%) | 7 | (41.2) | 0 | (0.0) |
Nursing home residents, n (%) | 0 | (0.0) | 0 | (0.0) |
Smoking history, n (%) | 7 | (41.2) | 0 | (0.0) |
Patients with underlying disease | ||||
Diabetes mellitus, n (%) | 2 | (11.8) | 0 | (0.0) |
Bronchial asthma, n (%) | 3 | (17.6) | 0 | (0.0) |
COPDa, n (%) | 3 | (17.6) | 0 | (0.0) |
Liver cirrhosis, n (%) | 0 | (0.0) | 0 | (0.0) |
Renal failure, n (%) | 2 | (11.8) | 0 | (0.0) |
Heart failure, n (%) | 1 | (5.9) | 0 | (0.0) |
Malignant neoplasm, n (%) | 4 | (23.5) | 1 | (25.0) |
Patients vaccinated against S. pneumoniae, n (%) | 1 | (5.9) | 1 | (25.0) |
Patients with prior antibiotic therapy, n (%) | 4 | (23.5) | 0 | (0.0) |
Body temperature, °C, median (range) | 37.8 | (36.3–39.9) | 39.1 | (38.3–39.4) |
White blood cells, /μL, median (range) | 11,900 | (6100–30,700) | 9000 | (6600–13,300) |
C-reactive protein, mg/dL, median (range) | 15.11 | (0.92–36.7) | 17.5 | (14.1–34.7) |
PORTb score, points, median (range) | 87 | (38–236) | 92.5 | (86–101) |